- Clinical and regulatory sources
Evidence and guidance behind the website language
The sources below are for education and website governance. Clinical decisions must rely on current prescribing information, professional judgment, and applicable law.
Medication and weight management
- U.S. FDA: Zepbound approval for chronic weight management
- U.S. FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- NIDDK: Prescription medications to treat overweight and obesity
- NIDDK: Treatment for overweight and obesity
- STEP 1 extension: Weight regain after withdrawal of semaglutide
- SURMOUNT-4: Tirzepatide continuation and withdrawal trial
Nutrition & Sustainable Weight Management
Review links and content periodically. Product labeling, approvals, shortages, compounding rules, telehealth laws, and professional guidance can change.
Important Information
These resources are provided for education and website governance. They do not replace professional medical judgment or current prescribing information
Last reviewed
August 2026
Important Information
These resources are provided for education and website governance. They do not replace professional medical judgment or current prescribing information
Last reviewed
August 2026